466 related articles for article (PubMed ID: 22310613)
21. Understanding the significance of low-level preformed donor-specific anti-HLA antibodies in renal transplant patients.
Wu P; Everly MJ; Jin J; Mao Y; Chen J
Clin Transpl; 2011; ():365-8. PubMed ID: 22755432
[TBL] [Abstract][Full Text] [Related]
22. Alemtuzumab induction in deceased donor kidney transplantation.
Shin M; Song SH; Kim JM; Kwon CH; Joh JW; Lee SK; Kim SJ
Transplant Proc; 2011; 43(6):2365-78. PubMed ID: 21839271
[TBL] [Abstract][Full Text] [Related]
23. Successful kidney transplantation after desensitization using plasmapheresis, low-dose intravenous immunoglobulin, and rituximab in highly sensitized patients: a single-center experience.
Jin MK; Cho JH; Kwon O; Hong KD; Choi JY; Yoon SH; Park SH; Kim YL; Kim CD
Transplant Proc; 2012 Jan; 44(1):200-3. PubMed ID: 22310614
[TBL] [Abstract][Full Text] [Related]
24. Analysis of transplant outcomes after five or six human leukocyte antigen-mismatched living donor kidney transplantation.
Lee HS; Kim MS; Kim YS; Joo DJ; Ju MK; Kim SJ; Kim SI; Huh KH; Park K
Transplant Proc; 2012 Jan; 44(1):273-5. PubMed ID: 22310631
[TBL] [Abstract][Full Text] [Related]
25. Preformed donor-specific antibodies and risk of antibody-mediated rejection in repeat renal transplantation.
Tsapepas DS; Vasilescu R; Tanriover B; Coppleson Y; Rekhtman Y; Hardy MA; Dube G; Crew RJ; Ratner LE; Cohen DJ; Mohan S
Transplantation; 2014 Mar; 97(6):642-7. PubMed ID: 24637863
[TBL] [Abstract][Full Text] [Related]
26. Impact of human leukocyte antigen matching and recipients' panel reactive antibodies on two-year outcome in presensitized renal allograft recipients.
Meng HL; Jin XB; Li XT; Wang HW; Lü JJ
Chin Med J (Engl); 2009 Feb; 122(4):420-6. PubMed ID: 19302748
[TBL] [Abstract][Full Text] [Related]
27. The effect of donor-recipient relationship on long-term outcomes of living related donor renal transplantation.
Choi JY; Kwon OJ; Kang CM
Transplant Proc; 2012 Jan; 44(1):257-60. PubMed ID: 22310626
[TBL] [Abstract][Full Text] [Related]
28. Abrogation of antibodies improves outcome of renal transplantation.
Trivedi HL; Vanikar AV; Gumber MR; Patel HV; Shah PR; Kute VB
Transplant Proc; 2012 Jan; 44(1):241-7. PubMed ID: 22310623
[TBL] [Abstract][Full Text] [Related]
29. Living-donor kidney transplant in T-cell and B-cell flow cytometry crossmatch-positive patients.
Terasaka S; Kitada H; Okabe Y; Kawanami S; Noguchi H; Miyamoto K; Tsuchimoto A; Masutani K; Tanaka M
Exp Clin Transplant; 2014 Jun; 12(3):227-32. PubMed ID: 24907723
[TBL] [Abstract][Full Text] [Related]
30. Anti-human leukocyte antigen and donor-specific antibodies detected by luminex posttransplant serve as biomarkers for chronic rejection of renal allografts.
Lachmann N; Terasaki PI; Budde K; Liefeldt L; Kahl A; Reinke P; Pratschke J; Rudolph B; Schmidt D; Salama A; Schönemann C
Transplantation; 2009 May; 87(10):1505-13. PubMed ID: 19461487
[TBL] [Abstract][Full Text] [Related]
31. Frequent false-positive reactions in pronase-treated T-cell flow cytometric cross-match tests.
Park H; Lim YM; Han BY; Hyun J; Song EY; Park MH
Transplant Proc; 2012 Jan; 44(1):87-90. PubMed ID: 22310587
[TBL] [Abstract][Full Text] [Related]
32. Impact of flow cytometry crossmatch B-cell positivity on living renal transplantation.
Kurihara K; Kitada H; Miura Y; Terasaka S; Kaku K; Miyamoto K; Tsuchimoto A; Masutani K; Tanaka M
Transplant Proc; 2013 Oct; 45(8):2903-6. PubMed ID: 24157001
[TBL] [Abstract][Full Text] [Related]
33. Cytotoxic flow cytometric crossmatch in renal transplantation: a single assay to simultaneously detect antibody binding and cytotoxicity.
Thammanichanond D; Athimang W; Paisooksantivatana K; Mongkolsuk T; Ingsathit A; Worawichawong S; Kitpoka P; Jirasiritham S; Kantachuvesiri S
Transplant Proc; 2012 Jan; 44(1):62-5. PubMed ID: 22310580
[TBL] [Abstract][Full Text] [Related]
34. Pretransplant immunologic risk assessment of kidney transplant recipients with donor-specific anti-human leukocyte antigen antibodies.
Marfo K; Ajaimy M; Colovai A; Kayler L; Greenstein S; Lubetzky M; Gupta A; Kamal L; de Boccardo G; Masiakos P; Kinkhabwala M; Akalin E
Transplantation; 2014 Nov; 98(10):1082-8. PubMed ID: 24873780
[TBL] [Abstract][Full Text] [Related]
35. Long-term post transplant alloantibody monitoring: a single center experience.
Ntokou IS; Boletis JN; Apostolaki M; Vrani V; Zavos G; Kostakis A; Iniotaki A
Clin Transpl; 2011; ():341-50. PubMed ID: 22755429
[TBL] [Abstract][Full Text] [Related]
36. Combination of Total Lymphoid Irradiation, Low-Dose IVIG and ATG as Rescue Therapy for Highly Sensitized and Antibody-Mediated Rejection Renal Transplant Recipients.
Zhu D; Qi G; Tang Q; Li L; Yang C; Lin M; Wu B; Xu M; Cai J; Zhu T; Rong R
Clin Transpl; 2014; ():215-21. PubMed ID: 26281148
[TBL] [Abstract][Full Text] [Related]
37. Specific and durable elimination of antibody to donor HLA antigens in renal-transplant patients.
Zachary AA; Montgomery RA; Ratner LE; Samaniego-Picota M; Haas M; Kopchaliiska D; Leffell MS
Transplantation; 2003 Nov; 76(10):1519-25. PubMed ID: 14657698
[TBL] [Abstract][Full Text] [Related]
38. Targeted monitoring of donor-specific HLA antibodies following renal transplantation.
Almeshari K; Pall A; Chaballout A; Elgamal H; Almana H; Alzayer F; Abaalkhail N; Altalhi M
Clin Transpl; 2011; ():395-400. PubMed ID: 22755437
[TBL] [Abstract][Full Text] [Related]
39. The presence of donor-specific antibodies in renal transplantation.
Tozkir H; Sağiroğlu T; Kiliçarslan-Ayna T; Tan S; Çopuroğlu E; Sağiroğlu G; Sari G; Gürkan H; Sezer A
Transplant Proc; 2012; 44(6):1667-9. PubMed ID: 22841240
[TBL] [Abstract][Full Text] [Related]
40. Significance of low-level DSA detected by solid-phase assay in association with acute and chronic antibody-mediated rejection.
Hirai T; Kohei N; Omoto K; Ishida H; Tanabe K
Transpl Int; 2012 Sep; 25(9):925-34. PubMed ID: 22764746
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
